Barrett's esophagus (disorder)
Clinical Trial: AspECT
Year Started: 2005
AspECT: A Phase III, Randomised Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia. Trial has 10-year follow up period with samples collected throughout. Patient age groups given in the Sample Sets are the age of the patients at trial randomisation
- Access:
- Open to applicants
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- Commercial restriction, DNA restriction
Associated Data Type | Procurement Timeframe |
---|---|
Followup records | 0 - 3 months |
Pathology records | 3 - 6 months |
Physiological/biochemical measurements | 0 - 3 months |
Treatment records | 0 - 3 months |
Female
Young adult (18 - 40 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 51 - 75% |
Whole blood | -60°C to -85°C | N/A | Not applicable | 51 - 75% |
Malignant tumor of ovary (disorder)
Clinical Trial: OCTOVA
Year Started: 2017
See ClinicalTrials.gov reference NCT03117933 for more information about the study. Whole blood and plasma samples pre and post-treatment with i.PARPi ii. control or iii. PARPi & anti-angiogenic. FFPE diagnostoc tumour sample.
- Access:
- Access restricted at present
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Female
Adult (> 40 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Not applicable | 0 - 10% | |
Tissue specimen | Surgical procedure (procedure) | RT | N/A | Affected | 0 - 10% |
Whole blood | -60°C to -85°C | N/A | Not applicable | 0 - 10% |